Rapid conversion from one monoamine oxidase inhibitor to another

Journal of Clinical Psychiatry

Volumn 58, Issue 7, 1997, Pages 307-310

  Szuba, Martin P ^a,b   Hornig Rohan, Mädy ^a   Amsterdam, Jay D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b The Science Center Philadelphia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CHLORAL HYDRATE; CLOMIPRAMINE; CLONAZEPAM; HALOPERIDOL; HYDROCHLOROTHIAZIDE; LITHIUM; LORAZEPAM; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; OXAZEPAM; PHENELZINE; RANITIDINE; RISPERIDONE; TRANYLCYPROMINE; TRAZODONE; TRIFLUOPERAZINE; TYRAMINE; VALPROIC ACID;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DIET; FEMALE; HEART PALPITATION; HUMAN; INSOMNIA; MALE; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RESTLESSNESS; SIDE EFFECT; VERTIGO; WITHDRAWAL SYNDROME;

EID: 0030877235     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/jcp.v58n0704     Document Type: Article

References (23)

1. Quitkin FM, Harrison W, Liebowitz M, et al. Defining the boundaries of atypical depression. J Clin Psychiatry 1984;45(7, sec 2): 19-21
2. Liebowitz MR, Quitkin FM, Stewart J, et al. Effect of panic attacks on the treatment of atypical depressives. Psychopharmacol Bull 1985;21: 558-561
3. Robinson DS, Kurts NM. Monoamine oxidase inhibiting drugs: pharmacologic and therapeutic issues. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. 3rd ed. New York, NY: Raven Press; 1987:1297-1304
4. Thase ME, Malinger AG, McKnight D, et al. Treatment of imipramine-resistant recurrent depression, IV: a double-blind crossover of tranylcypromine for anergic bipolar depression. Am J Psychiatry 1992;149:195-198
5. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987;144:1403-1411
6. Thase ME, Frank E, Mallinger AG, et al. Treatment of imipramine-resistant recurrent depression. III: efficacy of monoamine oxidase inhibitors J Clin Psychiatry 1992;53:5-11
7. Lader M. Combined use of tricyclic antidepressants and monoamine oxidase inhibitors. J Clin Psychiatry 1983;44(9, sec 2):20-24
8. White K, Simpson G. The combined use of MAOIs and tricyclics. J Clin Psychiatry 1984;45(7, sec 2):67-69
9. Marley E, Wozniak KM. Clinical and experimental aspects of interactions between amine oxidase inhibitors and amine re-uptake inhibitors. Psychol Med 1983;13:735-749
10. Stern TA, Schwartz JH, Shuster JL. Catastrophic illness associated with the combination of clomipramine, phenelzine and chlorpromazine. Ann Clin Psychiatry 1992;4:81-85
11. Blackwell B. Monoamine oxidase inhibitor interactions with other drugs. J Clin Psychopharmacol 1991;11:55-59
12. Nierenberg AA, Amsterdam JD. Treatment-resistant depression: definition and treatment approaches. J Clin Psychiatry 1990;51(6, suppl):39-47
13. Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In: Goodman LS, Gilman A, eds. The Pharmacological Basis of Therapeutics. 7th ed New York, NY: Macmillan; 1985:387-444
14. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148: 705-713.
15. True BV, Alexander B, Carter B. Switching MAO inhibitors. Drug Intelligence and Clinical Pharmacy 1985;19:825-827
16. Nardil (phenelzine). Physicians' Desk Reference. 50th ed. Montvale, NJ: Medical Economics; 1996:1920-1922
17. Elis J, Laurence DR, Mattie H, et al. Modification of monoamine oxidase inhibitors on the effects of some sympathomimetics on blood pressure. BMJ 1967;2:75-78
18. Trinker FR, Fearn HJ, McCulloch MW, et al. Experimental observations on the effects of adrenaline after treatment with antidepressant monoamine oxidase inhibitor drugs. Aust Dent J 1967;12:297-303
19. Amsterdam JD, Rosenzweig M, Hornig-Rohan M. Chlorimipramine (CMI) augmentation in refractory depression [abstract]. Presented at the Third International Conference on Refractory Depression; October 18-21, 1995; Napa, Calif
20. Pamate (tranylcypramine). Physicians' Desk Reference. 50th ed. Montvale, NJ: Medical Economics; 1996:2503-2505
21. Gelenberg AJ. Switching MAO inhibitors. Biological Therapies in Psychiatry 1984;7:36
22. Keck P, Pope HG, Nierenberg A. Autoinduction of hypertensive reactions by tranylcypromine. J Clin Psychopharmacol 1989;9:48-51
23. Da Motta T, Cordás TA. Autoinduction of hypertensive reactions by tranylcypromine. J Clin Psychopharmacol 1990;10:23